The Food and Drug Administration issued an alert and specifically mentioned 26 eye drop products from a number of brands.
Share:
More In Business
Biotechnology company Regeneron buying 23andMe for $256 million
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
New York ends paper routes for younger kids
New York's recently approved budget makes clear that paper routes are not allowed for anyone under 14 years old.
From Viral Moments to Vital Conversations: Rachel Lindsay & Van Lathan On 'Higher Learning'
Celebrating 5 years of the hit podcast 'Higher Learning' with hosts Rachel Lindsay and Van Lathan on the floor of the New York Stock Exchange. Watch!
Returns, Reimagined: How ReturnPro Uses Smart Tech to Simplify Send-Backs
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
Big Business This Week: Big Blue gets bigger, without the blues
IBM is up 20% this year, thanks to AI consulting. Plus: UnitedHealthCare, Boeing, FedEx, Apple, Nissan, Dick's, Burberry, and HBO (Max). Whew!
